139 related articles for article (PubMed ID: 35354757)
1. Acute Coronary Syndrome After Inactivated SARS-COV-2 Vaccine.
Panthong S; Vimonsuntirungsri T; Thapanasuta M; Wanlapakorn C; Udayachalerm W; Ariyachaipanich A
Int Heart J; 2022; 63(2):388-392. PubMed ID: 35354757
[TBL] [Abstract][Full Text] [Related]
2. Single-cell transcriptomic atlas reveals distinct immunological responses between COVID-19 vaccine and natural SARS-CoV-2 infection.
Wang Y; Wang X; Luu LDW; Li J; Cui X; Yao H; Chen S; Fu J; Wang L; Wang C; Yuan R; Cai Q; Huang X; Huang J; Li Z; Li S; Zhu X; Tai J
J Med Virol; 2022 Nov; 94(11):5304-5324. PubMed ID: 35859327
[TBL] [Abstract][Full Text] [Related]
3. [The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19].
Topkaya AE; Keskin AÜ; Dalan AB; Çıragil P
Mikrobiyol Bul; 2022 Jan; 56(1):139-142. PubMed ID: 35088968
[TBL] [Abstract][Full Text] [Related]
4. Effect of Inactivated SARS-CoV-2 Vaccine on Thyroid Function and Autoimmunity Within 28 Days After the Second Dose.
Li L; Chen X; Li B; Liu D; Liu Y; Mo R; Lai F; Liu R; Peng S; Li Y; Liu M; Xiao H
Thyroid; 2022 Sep; 32(9):1051-1058. PubMed ID: 35864805
[No Abstract] [Full Text] [Related]
5. Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization.
Wong CKH; Xiong X; Lau KTK; Chui CSL; Lai FTT; Li X; Chan EWY; Wan EYF; Au ICH; Cowling BJ; Lee CK; Wong ICK
BMC Med; 2022 Mar; 20(1):119. PubMed ID: 35296305
[TBL] [Abstract][Full Text] [Related]
6. Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
Melo-González F; Soto JA; González LA; Fernández J; Duarte LF; Schultz BM; Gálvez NMS; Pacheco GA; Ríos M; Vázquez Y; Rivera-Pérez D; Moreno-Tapia D; Iturriaga C; Vallejos OP; Berríos-Rojas RV; Hoppe-Elsholz G; Urzúa M; Bruneau N; Fasce RA; Mora J; Grifoni A; Sette A; Weiskopf D; Zeng G; Meng W; González-Aramundiz JV; González PA; Abarca K; Ramírez E; Kalergis AM; Bueno SM
Front Immunol; 2021; 12():747830. PubMed ID: 34858404
[TBL] [Abstract][Full Text] [Related]
7. Type 1 Kounis Syndrome Induced by Inactivated SARS-COV-2 Vaccine.
Özdemir İH; Özlek B; Özen MB; Gündüz R; Bayturan Ö
J Emerg Med; 2021 Oct; 61(4):e71-e76. PubMed ID: 34148772
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
9. Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Postvaccination ASIA Syndrome.
İremli BG; Şendur SN; Ünlütürk U
J Clin Endocrinol Metab; 2021 Aug; 106(9):2600-2605. PubMed ID: 34043800
[TBL] [Abstract][Full Text] [Related]
10. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
Front Immunol; 2021; 12():802858. PubMed ID: 35003131
[TBL] [Abstract][Full Text] [Related]
11. Comparison of immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccine (CoronaVac) in previously SARS-CoV-2 infected and uninfected health care workers.
Soysal A; Gönüllü E; Karabayır N; Alan S; Atıcı S; Yıldız İ; Engin H; Çivilibal M; Karaböcüoğlu M
Hum Vaccin Immunother; 2021 Nov; 17(11):3876-3880. PubMed ID: 34324409
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series.
Assawasaksakul T; Sathitratanacheewin S; Vichaiwattana P; Wanlapakorn N; Poovorawan Y; Kittanamongkolchai W
RMD Open; 2021 Dec; 7(3):. PubMed ID: 34862313
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of alpha, gamma, and D614G SARS-CoV-2 variants by CoronaVac vaccine-induced antibodies.
Fernández J; Bruneau N; Fasce R; Martín HS; Balanda M; Bustos P; Ulloa S; Mora J; Ramírez E
J Med Virol; 2022 Jan; 94(1):399-403. PubMed ID: 34460119
[TBL] [Abstract][Full Text] [Related]
14. Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine.
Hunsawong T; Fernandez S; Buathong R; Khadthasrima N; Rungrojchareonkit K; Lohachanakul J; Suthangkornkul R; Tayong K; Huang AT; Klungthong C; Chinnawirotpisan P; Poolpanichupatam Y; Jones AR; Lombardini ED; Wacharapluesadee S; Putcharoen O
Emerg Infect Dis; 2021 Dec; 27(12):3178-3180. PubMed ID: 34559045
[TBL] [Abstract][Full Text] [Related]
15. Safety and Adverse Effects of Inactive SARS-Cov-2 Vaccine (CoronaVac) in Health Care Professionals.
Guzel EC; Yildiz T; Buyukkiyici O; Dombaz OE
J Pak Med Assoc; 2022 Sep; 72(9):1792-1796. PubMed ID: 36280978
[TBL] [Abstract][Full Text] [Related]
16. Acute Ischaemic Stroke Incidence after Coronavirus Vaccine in Indonesia: Case Series.
Hidayat R; Diafiri D; Zairinal RA; Arifin GR; Azzahroh F; Widjaya N; Fani DN; Mesiano T; Kurniawan M; Al Rasyid ; Giantini A; Haris S
Curr Neurovasc Res; 2021; 18(3):360-363. PubMed ID: 34579636
[TBL] [Abstract][Full Text] [Related]
17. [Factors Affecting Side Effects, Seroconversion Rates and Antibody Response After Inactivated SARS-CoV-2 Vaccination in Healthcare Workers].
Şenol Akar Ş; Akçalı S; Özkaya Y; Gezginci FM; Cengiz Özyurt B; Deniz G; Karadağ Yalçın F; Özer D; Dündar Erbay P; Eser E
Mikrobiyol Bul; 2021 Oct; 55(4):519-538. PubMed ID: 34666653
[TBL] [Abstract][Full Text] [Related]
18. Should a third booster dose be scheduled after two doses of CoronaVac? A single-center experience.
Yigit M; Ozkaya-Parlakay A; Cosgun Y; Ince YE; Bulut YE; Senel E
J Med Virol; 2022 Jan; 94(1):287-290. PubMed ID: 34487373
[TBL] [Abstract][Full Text] [Related]
19. False Coronavirus Disease 2019 Cases due to Contamination by Inactivated Virus Vaccine.
To KK; Li X; Lung DC; Ip JD; Chan WM; Chu AW; Yip CC; Chen JHK; Poon RW; Tsoi HW; Lai RW; To WK; Ren L; Li M; Cao Y; Xie XS; Jin DY; Yuen KY
Clin Infect Dis; 2022 Apr; 74(8):1485-1488. PubMed ID: 34498683
[TBL] [Abstract][Full Text] [Related]
20. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
Costa Clemens SA; Weckx L; Clemens R; Almeida Mendes AV; Ramos Souza A; Silveira MBV; da Guarda SNF; de Nobrega MM; de Moraes Pinto MI; Gonzalez IGS; Salvador N; Franco MM; de Avila Mendonça RN; Queiroz Oliveira IS; de Freitas Souza BS; Fraga M; Aley P; Bibi S; Cantrell L; Dejnirattisai W; Liu X; Mongkolsapaya J; Supasa P; Screaton GR; Lambe T; Voysey M; Pollard AJ;
Lancet; 2022 Feb; 399(10324):521-529. PubMed ID: 35074136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
